408 related articles for article (PubMed ID: 23890183)
1. Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
Melcangi RC; Caruso D; Abbiati F; Giatti S; Calabrese D; Piazza F; Cavaletti G
J Sex Med; 2013 Oct; 10(10):2598-603. PubMed ID: 23890183
[TBL] [Abstract][Full Text] [Related]
2. Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma.
Caruso D; Abbiati F; Giatti S; Romano S; Fusco L; Cavaletti G; Melcangi RC
J Steroid Biochem Mol Biol; 2015 Feb; 146():74-9. PubMed ID: 24717976
[TBL] [Abstract][Full Text] [Related]
3. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients.
Melcangi RC; Santi D; Spezzano R; Grimoldi M; Tabacchi T; Fusco ML; Diviccaro S; Giatti S; Carrà G; Caruso D; Simoni M; Cavaletti G
J Steroid Biochem Mol Biol; 2017 Jul; 171():229-235. PubMed ID: 28408350
[TBL] [Abstract][Full Text] [Related]
4. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
Caruso D; Melis M; Fenu G; Giatti S; Romano S; Grimoldi M; Crippa D; Marrosu MG; Cavaletti G; Melcangi RC
J Neurochem; 2014 Aug; 130(4):591-7. PubMed ID: 24766130
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.
Basaria S; Jasuja R; Huang G; Wharton W; Pan H; Pencina K; Li Z; Travison TG; Bhawan J; Gonthier R; Labrie F; Dury AY; Serra C; Papazian A; O'Leary M; Amr S; Storer TW; Stern E; Bhasin S
J Clin Endocrinol Metab; 2016 Dec; 101(12):4669-4680. PubMed ID: 27662439
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects.
Irwig MS
J Clin Psychiatry; 2012 Sep; 73(9):1220-3. PubMed ID: 22939118
[TBL] [Abstract][Full Text] [Related]
7. Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia.
Irwig MS
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):248-53. PubMed ID: 25871957
[TBL] [Abstract][Full Text] [Related]
8. Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain.
Giatti S; Foglio B; Romano S; Pesaresi M; Panzica G; Garcia-Segura LM; Caruso D; Melcangi RC
Neuroendocrinology; 2016; 103(6):746-57. PubMed ID: 26646518
[TBL] [Abstract][Full Text] [Related]
9. Risk of Depression Associated With Finasteride Treatment.
Pompili M; Magistri C; Maddalena S; Mellini C; Persechino S; Baldessarini RJ
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):304-309. PubMed ID: 33814544
[TBL] [Abstract][Full Text] [Related]
10. Alterations of gut microbiota composition in post-finasteride patients: a pilot study.
Borgo F; Macandog AD; Diviccaro S; Falvo E; Giatti S; Cavaletti G; Melcangi RC
J Endocrinol Invest; 2021 Jun; 44(6):1263-1273. PubMed ID: 32951160
[TBL] [Abstract][Full Text] [Related]
11. A new look at the 5alpha-reductase inhibitor finasteride.
Finn DA; Beadles-Bohling AS; Beckley EH; Ford MM; Gililland KR; Gorin-Meyer RE; Wiren KM
CNS Drug Rev; 2006; 12(1):53-76. PubMed ID: 16834758
[TBL] [Abstract][Full Text] [Related]
12. Persistent sexual side effects of finasteride for male pattern hair loss.
Irwig MS; Kolukula S
J Sex Med; 2011 Jun; 8(6):1747-53. PubMed ID: 21418145
[TBL] [Abstract][Full Text] [Related]
13. Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition.
Diviccaro S; Giatti S; Borgo F; Barcella M; Borghi E; Trejo JL; Garcia-Segura LM; Melcangi RC
Psychoneuroendocrinology; 2019 Jan; 99():206-215. PubMed ID: 30265917
[TBL] [Abstract][Full Text] [Related]
14. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Lee S; Lee YB; Choe SJ; Lee WS
Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
[TBL] [Abstract][Full Text] [Related]
15. The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids.
Dušková M; Hill M; Stárka L
Horm Mol Biol Clin Investig; 2010 Jan; 1(2):95-102. PubMed ID: 25961975
[TBL] [Abstract][Full Text] [Related]
16. Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain.
Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baconi D; Stefanescu E; Baleanu BC; Balalau C; Constantin V; Paunica S
J Dermatolog Treat; 2016 Nov; 27(6):495-497. PubMed ID: 27046152
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
Di Loreto C; La Marra F; Mazzon G; Belgrano E; Trombetta C; Cauci S
PLoS One; 2014; 9(6):e100237. PubMed ID: 24959691
[TBL] [Abstract][Full Text] [Related]
18. Persistent sexual side effects of finasteride: could they be permanent?
Irwig MS
J Sex Med; 2012 Nov; 9(11):2927-32. PubMed ID: 22789024
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
[TBL] [Abstract][Full Text] [Related]
20. Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
Perez-Mora N; Velasco C; Bermüdez F
Skinmed; 2015; 13(3):179-83. PubMed ID: 26380503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
